Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2015

01-12-2015 | Original Article

Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran

Authors: Maliheh Charkhchian, Simin Samani, Ehsan Merat

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2015

Login to get access

Abstract

Background

Nephrolithiasis is a common clinical disorder with significant health and economic burden. We conducted this study to evaluate clinical and metabolic parameters in adult patients with history of renal calculi.

Materials and methods

A total of 213 patients with history of nephrolithiasis participated in this study. Evaluation included the measurement of serum calcium, uric acid, parathormone, renal function tests, urinalysis, and urinary tests for cystinuria. Also, parameters such as volume, creatinine, calcium, uric acid, citrate, and oxalate levels were measured on 24-h urine. All patients underwent urinary tract system sonography.

Results

Of total patients, 52 % were males and 48 % females. The mean age was 45.16 ± 13.16 years. Also, 51.2 % of subjects had positive family history of nephrolithiasis. The mean body mass index was (26.8 ± 4.2) kg/m2. The mean 24-h urine biochemical profiles were volume (1,748 ± 860 ml), Ca (183 ± 115), uric acid (544 ± 220), citrate (490 ± 351), and oxalate (17.1 ± 15.3) mg/day; urine calcium to creatinine ratio (0.15 ± 0.10) mg/mg, and urine calcium to weight ratio (2.4 ± 1.7) mg/kg. While there were weak positive correlations between the body mass index and urinary calcium (r = 0.101, P < 0.001) and uric acid (r = 0.200, P < 0.001), a weak negative correlation with urine pH (r = −0.104, P < 0.001) was found.

Conclusions

Urine calcium, uric acid, and oxalate excretion were low in our patients while urine citrate was relatively high. Higher BMI maybe a risk factor for nephrolithiasis.
Literature
1.
go back to reference Johnson CM, Wilson DM, O’Fallon WM et al (1979) Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 16:624–631CrossRefPubMed Johnson CM, Wilson DM, O’Fallon WM et al (1979) Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 16:624–631CrossRefPubMed
2.
go back to reference Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823CrossRefPubMed Stamatelou KK, Francis ME, Jones CA et al (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823CrossRefPubMed
4.
5.
go back to reference Robertson WG, Peacock M, Baker M et al (1983) Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol 55:595–598CrossRefPubMed Robertson WG, Peacock M, Baker M et al (1983) Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol 55:595–598CrossRefPubMed
6.
go back to reference Hamano S, Nakatsu H, Suzuki N et al (2005) Kidney stone disease and risk factors for coronary heart disease. Int J Urol 12:859–863CrossRefPubMed Hamano S, Nakatsu H, Suzuki N et al (2005) Kidney stone disease and risk factors for coronary heart disease. Int J Urol 12:859–863CrossRefPubMed
8.
go back to reference Maalouf NM, Cameron MA, Moe OW et al (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888CrossRefPubMed Maalouf NM, Cameron MA, Moe OW et al (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883–888CrossRefPubMed
9.
go back to reference Johri N, Cooper B, Robertson W et al (2010) An update and practical guide to renal stone management. Nephron Clin Pract 116:159–171CrossRef Johri N, Cooper B, Robertson W et al (2010) An update and practical guide to renal stone management. Nephron Clin Pract 116:159–171CrossRef
10.
go back to reference Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152CrossRefPubMed Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152CrossRefPubMed
11.
go back to reference Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73:489–496CrossRefPubMed Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73:489–496CrossRefPubMed
12.
go back to reference Parks JH, Coe FL (1986) A urinary calcium—citrate index for the evaluation of Nephrolithiasis. Kidney Int 30:85–90CrossRefPubMed Parks JH, Coe FL (1986) A urinary calcium—citrate index for the evaluation of Nephrolithiasis. Kidney Int 30:85–90CrossRefPubMed
13.
go back to reference Rendina D, Mossetti G, De Filippo G et al (2009) Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and obesity. Nephrol Dial Transplant 24:900–906CrossRefPubMed Rendina D, Mossetti G, De Filippo G et al (2009) Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and obesity. Nephrol Dial Transplant 24:900–906CrossRefPubMed
14.
go back to reference West B, Luke A, Durazo-Arvizu RA et al (2008) Metabolic syndrome and self-reported history of kidney stone: the National Health and Nutrition Examination Survey (NHANES lll) 1988-19994. Am J Kidney Dis 51:741–747CrossRefPubMed West B, Luke A, Durazo-Arvizu RA et al (2008) Metabolic syndrome and self-reported history of kidney stone: the National Health and Nutrition Examination Survey (NHANES lll) 1988-19994. Am J Kidney Dis 51:741–747CrossRefPubMed
15.
go back to reference Abate N, Chandalia M, Cabo-Chan V, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392CrossRefPubMed Abate N, Chandalia M, Cabo-Chan V, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392CrossRefPubMed
16.
go back to reference Pak CYC, Sakhaee K, Peterson RD et al (2001) Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60:757–761CrossRefPubMed Pak CYC, Sakhaee K, Peterson RD et al (2001) Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60:757–761CrossRefPubMed
17.
go back to reference Pak CYC, Hayashi Y, Arnold LH (1976) Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate. Proc Soc Exp Biol Med 153:83–87CrossRefPubMed Pak CYC, Hayashi Y, Arnold LH (1976) Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate. Proc Soc Exp Biol Med 153:83–87CrossRefPubMed
18.
go back to reference Pak CYC, Waters O, Arnold L et al (1977) Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate. J Clin Invest 59:426–431PubMedCentralCrossRefPubMed Pak CYC, Waters O, Arnold L et al (1977) Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate. J Clin Invest 59:426–431PubMedCentralCrossRefPubMed
19.
go back to reference Ettinger B, Tang A, Citron JT et al (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315:1386–1389CrossRefPubMed Ettinger B, Tang A, Citron JT et al (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315:1386–1389CrossRefPubMed
20.
go back to reference Butler R, Morris AD, Belch JJ et al (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746–751CrossRefPubMed Butler R, Morris AD, Belch JJ et al (2000) Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746–751CrossRefPubMed
Metadata
Title
Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran
Authors
Maliheh Charkhchian
Simin Samani
Ehsan Merat
Publication date
01-12-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1159-3

Other articles of this Issue 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.